Literature DB >> 15941969

Genetic variation in XPD, sun exposure, and risk of skin cancer.

Jiali Han1, Graham A Colditz, Jun S Liu, David J Hunter.   

Abstract

The XPD gene is involved in the nucleotide excision repair pathway removing DNA photoproducts induced by UV radiation. Genetic variation in XPD may exert a subtle effect on DNA repair capacity. We assessed the associations between two common nonsynonymous polymorphisms (Asp312Asn and Lys751Gln) with skin cancer risk in a nested case-control study within the Nurses' Health Study (219 melanoma, 286 squamous cell carcinoma, 300 basal cell carcinoma, and 874 controls) along with exploratory analysis on the haplotype structure of the XPD gene. There were inverse associations between the Lys751Gln and Asp312Asn polymorphisms and the risks of melanoma and squamous cell carcinoma. No association was observed between these two polymorphisms and basal cell carcinoma risk. We also observed that the association of the 751Gln allele with melanoma risk was modified by lifetime severe sunburns, cumulative sun exposure with a bathing suit, and constitutional susceptibility score (P for interaction = 0.03, 0.04, and 0.02 respectively). Similar interactions were also observed for the Asp312Asn. Our data suggest these two XPD nonsynonymous polymorphisms may be associated with skin cancer risk, especially for melanoma.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15941969     DOI: 10.1158/1055-9965.EPI-04-0846

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  28 in total

1.  A germline variant in the interferon regulatory factor 4 gene as a novel skin cancer risk locus.

Authors:  Jiali Han; Abrar A Qureshi; Hongmei Nan; Jiangwen Zhang; Yiqing Song; Qun Guo; David J Hunter
Journal:  Cancer Res       Date:  2011-01-26       Impact factor: 12.701

2.  Polymorphisms in genes involved in oxidative stress and their interactions with lifestyle factors on skin cancer risk.

Authors:  Chunyan He; Abrar A Qureshi; Jiali Han
Journal:  J Dermatol Sci       Date:  2010-07-15       Impact factor: 4.563

3.  The XPD Asp312Asn and Lys751Gln polymorphisms, corresponding haplotype, and pancreatic cancer risk.

Authors:  Li Jiao; Manal M Hassan; Melissa L Bondy; James L Abbruzzese; Douglas B Evans; Donghui Li
Journal:  Cancer Lett       Date:  2006-02-03       Impact factor: 8.679

4.  Genetic variants in the 53BP1 gene and skin cancer risk.

Authors:  Chunyan He; Hongmei Nan; Abrar A Qureshi; Jiali Han
Journal:  J Invest Dermatol       Date:  2010-08-05       Impact factor: 8.551

5.  Association study of genetic variation in DNA repair pathway genes and risk of basal cell carcinoma.

Authors:  Yuan Lin; Harvind S Chahal; Wenting Wu; Hyunje G Cho; Katherine J Ransohoff; Fengju Song; Jean Y Tang; Kavita Y Sarin; Jiali Han
Journal:  Int J Cancer       Date:  2017-05-31       Impact factor: 7.396

6.  Polymorphisms in XPD (Asp312Asn and Lys751Gln) genes, sunburn and arsenic-related skin lesions.

Authors:  Kathleen M McCarty; Thomas J Smith; Wei Zhou; Ernesto Gonzalez; Quazzi Quamruzzaman; Mahmuder Rahman; Golam Mahiuddin; Louise Ryan; Li Su; David C Christiani
Journal:  Carcinogenesis       Date:  2007-04-29       Impact factor: 4.944

7.  Comprehensive assessment of the association of ERCC2 Lys751Gln polymorphism with susceptibility to cutaneous melanoma.

Authors:  Yuhao Dong; Le Zhuang; Weiyuan Ma
Journal:  Tumour Biol       Date:  2013-02-03

8.  Interleukin and interleukin receptor gene polymorphisms and susceptibility to melanoma.

Authors:  Fangyi Gu; Abrar A Qureshi; Tianhua Niu; Peter Kraft; Qun Guo; David J Hunter; Jiali Han
Journal:  Melanoma Res       Date:  2008-10       Impact factor: 3.599

9.  Genetic variants in FGFR2 and FGFR4 genes and skin cancer risk in the Nurses' Health Study.

Authors:  Hongmei Nan; Abrar A Qureshi; David J Hunter; Jiali Han
Journal:  BMC Cancer       Date:  2009-06-06       Impact factor: 4.430

10.  Some molecular and clinical aspects of genetic predisposition to malignant melanoma and tumours of various site of origin.

Authors:  Tadeusz Debniak
Journal:  Hered Cancer Clin Pract       Date:  2007-06-15       Impact factor: 2.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.